Info
Deadline for application: 20 August 2021
Job summary
Location: Brussels
Details
The European Cancer Patient Coalition (ECPC) is a European umbrella organisation, set up in 2003, based in Brussels gathering over 450 cancer patient associations from 50 countries.
The ECPC are recruiting a Senior Research Projects Officer to manage the organisation s work in EU and third parties
funded projects in cancer. The Senior Research Projects Officer will be working with the various project files
of the organisation, contributing to EU and industry funded projects, and establishing good working relations with key stakeholders. This is an exciting opportunity for an experienced professional with sound educational and professional background.
John Stapleton has revealed that he has had a difficult year since the death of his wife last April.
The 75-year-old broadcaster s wife Lynn Faulds Wood, 72, who had Antiphospholipid Syndrome (APS), died in year following a massive stroke at their home at St Margarets in south west London.
Lynn was also diagnosed with bowel cancer 30 years ago when was given a 34 per cent chance of survival and after she got over the illness started campaigning to make people more aware of the early symptoms.
Sad: John Stapleton revealed on Lorraine on Thursday that he has had a difficult year since the death of his wife Lynn last April
01:27 PM
European health organisations have welcomed a draft decision allowing transfers of personal data to continue to flow freely between the EU and the UK.
In a joint letter, a group of health organisations said recognition of the adequacy of the UK data protection regime is “vital for the functioning of the European health sector”.
They urge the European Data Protection Board and member states to support the draft adequacy decision, so that it can be formal adopted.
The letter has been signed by the NHS Confederation, European Patients Forum (EPF), Cancer Research, the British Medical Association (BMA), European Organisation for Research and Treatment of Cancer (EOTRC), Federation of European Dental Competent Authorities and Regulators (FEDCAR), Standing Committee of European Doctors (CPME), European Brain Council, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), European Society for Paediatric Oncology (SIOPE), Europabio, Nanotechia, Association of t
Unnecessary loss of life, and how to avoid it - The potential of lung cancer screening
Published 2 months ago
Unnecessary loss of life – but not from COVID-19. At a time when the coronavirus infection is already inflicting a frightening death toll on the world from a previously unknown health threat, Europe cannot afford to tolerate another unnecessary and large-scale loss of life from a disease that has long been well recognized: lung cancer. But institutional neglect is causing unnecessary loss of life, according to oncologists, pulmonologists, radiotherapists, technology developers and patient representatives from across Europe. In a European Alliance for Personalised Medicine (EAPM) round table they focused on persistent delays in promoting the lung cancer screening programmes that could save thousands of life-years,
Stakeholders in the health sector widely welcomed the long-awaited Europe’s Beating Cancer Plan, unveiled on Wednesday (3 January), as a “new era for cancer care and cancer patients” which places the European Union at the forefront of research and innovation efforts.
The €4 billion flagship plan is a key pillar of the European Health Union, presented by President of the European Commission, Ursula von der Leyen, in November 2020 as part of creating a more secure, resilient and better-prepared EU.
With an emphasis on research and innovation, the cancer plan sets out a new EU approach to cancer which targets the entire disease pathway, from prevention to quality of life of cancer patients and survivors.